Fenwick represented AKASA (formerly known as Alpha Health), the only Unified Automation™ company for revenue cycle management in healthcare, in its $60 million Series B financing.

BOND led the financing round, and existing investors Andreessen Horowitz and Costanoa Ventures, among others, also participated.

The financing will enable the company to invest in high-caliber talent across the organization, scale operations to meet rapidly growing customer demand, continue to accelerate delivery of products to customers and further invest in sales and marketing to expand market presence. More information can be obtained from the company’s announcement.

The Fenwick transaction team was led by corporate partner Michael Esquivel and included counsel Malcolm Katz and associate Adam Conway.

Login

Don’t have an account yet?

Register